Neuropeptide Y-Y2 receptor knockout mice: Influence of genetic background on anxiety-related behaviors

Neuroscience

Volumn 176, Issue , 2011, Pages 420-430

  Zambello, E ^a   Zanetti, L ^a   Hedou G F ^a   Angelici, O ^a   Arban, R ^a   Tasan, R O ^b   Sperk, G ^b   Caberlotto, L ^a  

^a GSK   (Italy)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Depression; Dopamine; Noradrenaline; Serotonin; Stress; Yohimbine

Indexed keywords

DOPAMINE; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; FEMALE; FORCED SWIMMING TEST; GENETIC ASSOCIATION; IN VITRO STUDY; MALE; MAZE TEST; MICRODIALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; DOPAMINE; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRODIALYSIS; NOREPINEPHRINE; PHENOTYPE; RECEPTORS, NEUROPEPTIDE Y; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOHIMBINE;

EID: 79851512914     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.10.075     Document Type: Article

References (68)

1. Abercrombie E.D., Keller R.W., Zigmond M.J. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 1988, 27:897-904.
2. Abramowitz M., Stegun I.A. Handbook of mathematical functions with formulas, graphs, and mathematical tables 1972, 886. Dover, New York, NY. 9th ed.
3. Adewale A.S., Macarthur H., Westfall T.C. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors. Neuropharmacology 2007, 52:1396-1402.
4. Anisman H., Hayley S., Kelly O., Borowski T., Merali Z. Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behaviour: mouse strain-dependent outcomes. Behav Neurosci 2001, 115:443-454.
5. Assenmacher I., Barbanel G., Gaillet S., Givalois L., Ixart G., Malaval F., Mekaouche M., Siaud P., Szafarczyk A. Central regulation of ACTH release in stress. Ann N Y Acad Sci 1995, 771:41-54.
6. Bacchi F., Mathé A.A., Jimenez P., Stasi L., Arban R., Gerrard P., Caberlotto L. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides 2006, 27:3202-3207.
7. Belzung C. The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models. Behav Pharmacol 2001, 12:451-460.
8. Bond B.C., Virley D.J., Cairns N.J., Hunter A.J., Moore G.B., Moss S.J., Mudge A.W., Walsh F.S., Jazin E., Preece P. The quantification of gene expression in an animal model of brain ischaemia using TaqMan real-time RT-PCR. Brain Res Mol Brain Res 2002, 106:101-116.
9. Caberlotto L., Fuxe K., Overstreet D.H., Gerrard P., Hurd Y.L. Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Brain Res Mol Brain Res 1998, 59:58-65.
10. Caberlotto L., Fuxe K., Sedvall G., Hurd Y.L. Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum. Eur J Neurosci 1997, 9:1212-1225.
11. Caldarone B.J., Karthigeyan K., Harrist A., Hunsberger J.G., Wittmack E., King S.L., Jatlow P., Picciotto M.R. Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice. Psychopharmacology (Berl) 2003, 170:94-101.
12. Carlson G.P. Comparison of mouse strains for susceptibility to styrene-induced hepatotoxicity and pneumotoxicity. J Toxicol Environ Health 1997, 51:177-187.
13. Carvajal C., Dumont Y., Herzog H., Quirion R. Emotional behaviour in aged neuropeptide Y (NPY) Y2 knockout mice. J Mol Neurosci 2006, 28:239-245.
14. Charney D.S., Woods S.W., Heninger G.R. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder. Psychiatry Res 1989, 27:173-182.
15. Cook M.N., Bolivar V.J., McFadyen M.P., Flaherty L. Behavioural differences among 129 substrains: implications for knockout and transgenic mice. Behav Neurosci 2002, 116:600-611.
16. Crabbe J.C., Wahlsten D. Of mice and their environments. Science 2003, 299:1313-1314.
17. Crabbe J.C., Wahlsten D., Dudek B.C. Genetics of mouse behaviour: interactions with laboratory environment. Science 1999, 284:1670-1672.
18. Dazzi L., Motzo C., Imperato A., Serra M., Gessa G.L., Biggio G. Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators. J Pharmacol Exp Ther 1995, 273:241-247.
19. Ducottet C., Aubert A., Belzung C. Susceptibility to subchronic unpredictable stress is related to individual reactivity to threat stimuli in mice. Behav Brain Res 2004, 155:291-299.
20. Ducottet C., Belzung C. Correlations between behaviours in the elevated plus-maze and sensitivity to unpredictable subchronic mild stress: evidence from inbred strains of mice. Behav Brain Res 2005, 156:153-162.
21. Dumont Y., Fournier A., Quirion R. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J Neurosci 1998, 18:5565-5574.
22. Dumont Y., Fournier A., St-Pierre S., Quirion R. Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse 1996, 22:139-158.
23. Feenstra M.G., Botterblom M.H., van Uum J.F. Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors. J Neurochem 1998, 70:1104-1113.
24. Franklin B.J., Paxinos G. The mouse brain in stereotaxic coordinates 2003, Academic Press, Sydney.
25. Garcia A.S., Barrera G., Burke T.F., Ma S., Hensler J.G., Morilak D.A. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment. J Neurochem 2004, 91:683-693.
26. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996, 382:168-171.
27. Gobbi M., Gariboldi M., Piwko C., Hoyer D., Sperk G., Vezzani A. Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J Neurochem 1998, 70:1615-1622.
28. Greco B., Carli M. Reduced attention and increased impulsivity in mice lacking NPY Y2 receptors: relation to anxiolytic-like phenotype. Behav Brain Res 2006, 169:325-334.
29. Griebel G., Belzung C., Perrault G., Sanger D.J. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) 2000, 148:164-170.
30. Gustafson E.L., Smith K.E., Durkin M.M., Walker M.W., Gerald C., Weinshank R., Branchek T.A. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Brain Res Mol Brain Res 1997, 46:223-235.
31. Heidbreder C.A., Lacroix L., Atkins A.R., Organ A.J., Murray S., West A., Shah A.J. Development and application of a sensitive high performance ion-exchange chromatography method for the simultaneous measurement of dopamine, 5-hydroxytryptamine and norepinephrine in microdialysates from the rat brain. J Neurosci Methods 2001, 112:135-144.
32. Heilig M. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 1995, 59:201-205.
33. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
34. Heilig M., Zachrisson O., Thorsell A., Ehnvall A., Mottagui-Tabar S., Sjogren M., Asberg M., Ekman R., Wahlestedt C., Agren H. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res 2004, 38:113-121.
35. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., Tecott L.H. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A 1998, 95:15049-15054.
36. Jacobson L.H., Cryan J.F. Feeling strained?. Influence of genetic background on depression-related behavior in mice: a review. Behav Genet 2007, 37:171-213.
37. Johnston A.L., File S.E. Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites. Pharmacol Biochem Behav 1989, 32:151-156.
38. Karlsson R.M., Choe J.S., Cameron H.A., Thorsell A., Crawley J.N., Holmes A., Heilig M. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology 2008, 195:547-557.
39. Kask A., Rago L., Harro J. Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats. Brain Res 1998, 788:345-348.
40. King P.J., Widdowson P.S., Doods H.N., Williams G. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices. J Neurochem 1999, 73:641-646.
41. Larsen P.J., Sheikh S.P., Jakobsen C.R., Schwartz T.W., Mikkelsen J.D. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur J Neurosci 1993, 5:1622-1637.
42. Lathe R. The individuality of mice. Genes Brain Behav 2004, 3:317-327.
43. Lesch K.P., Zeng Y., Reif A., Gutknecht L. Anxiety-related traits in mice with modified genes of the serotonergic pathway. Eur J Pharmacol 2003, 480:185-204.
44. Mason K., Heal D.J., Stanford S.C. The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty. Pharmacol Biochem Behav 1998, 60:321-327.
45. Mineur Y.S., Prasol D.J., Belzung C., Crusio W.E. Agonistic behaviour and unpredictable chronic mild stress in mice. Behav Genet 2003, 33:513-519.
46. Morris B.J. Neuronal localisation of neuropeptide Y gene expression in rat brain. J Comp Neurol 1989, 290:358-368.
47. Nakajima M., Inui A., Asakawa A., Momose K., Ueno N., Teranishi A., Baba S., Kasuga M. Neuropeptide Y produces anxiety via Y2-type receptors. Peptides 1998, 19:359-363.
48. Page M.E., Brown K., Lucki I. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action. Psychopharmacology (Berl) 2003, 165:194-201.
49. Page M.E., Szeliga P., Gasparini F., Cryan J.F. Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents. Psychopharmacology (Berl) 2005, 179:240-246.
50. Parks C.L., Robinson P.S., Sibille E., Shenk T., Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci U S A 1998, 95:10734-10739.
51. Paxinos G., Franklin B.J. The mouse brain in stereotaxic coordinates 1997, Academic Press, San Diego, CA. 2nd ed.
52. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 1986, 24:525-529.
53. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
54. Pothion S., Bizot J.C., Trovero F., Belzung C. Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 2004, 155:135-146.
55. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., Hen R. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A 1998, 95:14476-14481.
56. Russell V.A. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat. Behav Brain Res 2002, 130:191-196.
57. Sainsbury A., Schwarzer C., Couzens M., Fetissov S., Furtinger S., Jenkins A., Cox H.M., Sperk G., Hokfelt T., Herzog H. Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci U S A 2002, 99:8938-8943.
58. Sajdyk T.J., Schober D.A., Smiley D.L., Gehlert D.R. Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala. Pharmacol Biochem Behav 2002, 71:419-423.
59. Shanks N., Anisman H. Escape deficits induced by uncontrollable foot-shock in recombinant inbred strains of mice. Pharmacol Biochem Behav 1993, 46:511-517.
60. Shaw JL, Gehlert DR (2007) Monoaminergic alteration in the NPY Y2 receptor deficient mouse brain. In: Proceeding of the 37th annual meeting of the Society for Neuroscience, Poster 352.3/G8.
61. Tanda G., Bassareo V., Di Chiara G. Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology (Berl) 1996, 123:127-130.
62. Tasan R.O., Nguyen N.K., Weger S., Sartori S.B., Singewald N., Heilbronn R., Herzog H., Sperk G. The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci 2010, 30:6282-6290.
63. Tschenett A., Singewald N., Carli M., Balducci C., Salchner P., Vezzani A., Herzog H., Sperk G. Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 2003, 18:143-148.
64. Van de Weerd H.A., Bulthuis R.J., Bergman A.F., Schlingmann F., Tolboom J., Van Loo P.L., Remie R., Baumans V., Van Zutphen L.F. Validation of a new system for the automatic registration of behavior in mice and rats. Behav Processes 2001, 53:11-20.
65. Voikar V., Koks S., Vasar E., Rauvala H. Strain and gender differences in the behaviour of mouse lines commonly used in transgenic studies. Physiol Behav 2001, 72:271-281.
66. Widdowson P.S., Halaris A.E. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain. Brain Res 1991, 539:196-202.
67. Winstanley C.A., Theobald D.E., Dalley J.W., Cardinal R.N., Robbins T.W. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex 2006, 16:106-114.
68. Zambello E., Jimenez-Vasquez P.A., El Khoury A., Mathe A.A., Caberlotto L. Acute stress differentially affects corticotropin-releasing hormone mRNA expression in the central amygdala of the "depressed" flinders sensitive line and the control flinders resistant line rats. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:651-661.